When was Bristol-Myers Squibb founded?

Bristol-Myers Squibb was founded in 1887 and raised its 1st funding round 121 years after it was founded.

Where is Bristol-Myers Squibb located?

Bristol-Myers Squibb is headquartered in New York City, United States. It is registered at Park Rapids, Minnesota.

How many employees does Bristol-Myers Squibb have?

As of Apr 30, 2026, the latest employee count at Bristol-Myers Squibb is 38151.

Is Bristol-Myers Squibb a funded company?

Bristol-Myers Squibb is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Oct 26, 2008.

When was the latest funding round of Bristol-Myers Squibb?

Bristol-Myers Squibb's latest funding was a $***** Grant (prize money) round on Sep 01, 2019, with participation from 1 investor.

What is the annual revenue of Bristol-Myers Squibb?

Annual revenue of Bristol-Myers Squibb is more than $1B as on Dec 31, 2024

Where does Bristol-Myers Squibb rank among its competitors?

Bristol-Myers Squibb ranks 23rd amongst 1801 active competitors, of which 89 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Bristol-Myers Squibb?

Bristol-Myers Squibb's top competitors include AbbVie, Amgen and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Bristol-Myers Squibb - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis. It discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. The company has multiple marketed products for cancer, HIV/AIDS, cardiovascular diseases, rheumatoid arthritis, and hepatitis. The pipeline includes multiple molecules (small molecule and biologics) at various stages of clinical trials. It was honored with the ALCF award given to organizations and individuals working towards fighting lung cancer. In 2022, the company recorded annual revenues of $45.85B and a net profit of $7.31B.

Website: bms.com
Social
Email ID: *****@bms.com
Phone Number: +1 **********
Registered Address: Park Rapids, Minnesota

Key Metrics

Founded Year

1887

Location

New York City, United States

Stage

Public

Latest Funding Round

Grant (prize money), Sep 01, 2019, $*****

Investors

Berkshire Hathaway & 8 more

Ranked

23^rd among 1801 active competitors

Annual Revenue

$1B+ as on Dec 31, 2024

Employee Count

38,151 as on Apr 30, 2026

Investment & Acquisitions

RatioTX & 109 more

Similar Companies

AbbVie & 1828 more

Exit Details

Public

View Bristol-Myers Squibb's full profile

Bristol-Myers Squibb is associated with 22 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BMS HOLDINGS CO. CIN: 825227071 , United States, Active	Dec 26, 999	-	1 (As on Dec 31, 2024)	-
BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED CIN: U24230MH2004FTC147232 , India, Active	Jun 30, 2004	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	129 (As on Feb 29, 2024)
IJC s.r.o. CIN: 01459783 , Czech Republic, Active	Mar 04, 2013	-	-
LLC Links Group s.r.o. CIN: 19659369 , Czech Republic, Active	Aug 28, 2023	-	-
BMS, P.C. CIN: 471494296 , United States, Active	Dec 31, 1999	-	2 (As on Dec 31, 2019)	-
BMS HOLDINGS, INC. CIN: 43-0634395 , United States, Active		-	153 (As on Dec 31, 2023)	-
GG Pharm Invest s.r.o. CIN: 19301448 , Czech Republic, Active	May 04, 2023	-	-
Juno Therapeutics, Inc. CIN: 1594864 , United States, Active	Aug 04, 2013	$100M - $500M (As on Dec 31, 2017)	730 (As on Dec 31, 2022)	-
Juno Therapeutics, Inc. CIN: 20181210146 , United States, Active	Mar 12, 2018	-	-	-
BMY WEB Group s.r.o. CIN: 05323088 , Czech Republic, Active	Aug 18, 2016	-	-
BMS SOFTWARE SERVICES LTD CIN: 11832023 , United Kingdom, Active	Feb 17, 2019	£0 - £1M (As on Feb 28, 2023)	1 (As on Feb 28, 2025)
BSM, spol. s r.o. CIN: 60709898 , Czech Republic, Active	May 30, 1994	-	-
TumorSHOT s.r.o. CIN: 09324925 , Czech Republic, Active	Jul 13, 2020	-	-
Stal Capuynehof Centrum voor paarden en persoonlijke groei CIN: 0781.582.646 , Belgium, Active	Feb 03, 2022	-	-	-
BMS HOLDINGS, INC. CIN: 430634395 , United States, Active	Dec 26, 999	-	158 (As on Dec 31, 2024)	-
Meyer spol. s r.o. CIN: 60851023 , Czech Republic, Active	Mar 28, 1994	-	-
Bristol-Myers Squibb CIN: - , Belgium, Active		-	-	-
BMS CO INC CIN: 131842479 , United States, Active	Dec 26, 999	-	13 (As on Dec 31, 2021)	-
Zymogenetics Inc CIN: 1129425 , United States, Active		$25M - $100M (As on Nov 12, 2008)	-	-
U.D.S. Kompania, s.r.o. CIN: 06308082 , Czech Republic, Active	Aug 01, 2017	-	-
Bristol Myers Squibb Co CIN: 14272 , United States, Active	Aug 10, 1933	$1B+ (As on Dec 31, 2024)	34100 (As on Dec 31, 2023)	-
Bristol-myers Squibb Company CIN: 19871015756 , United States, Active	Aug 27, 1952	$1B+ (As on Dec 31, 2025)	-	-

Bristol-Myers Squibb got listed on Jan 06, 1978.

Click here to take a look at Bristol-Myers Squibb's IPO in detail

Bristol-Myers Squibb has raised funding over 5 rounds. Its first funding round was on Oct 26, 2008. Its latest funding round was a Grant (prize money) round on Sep 01, 2019 for $*****. 1 investor participated in its latest round. Bristol-Myers Squibb has 9 institutional investors.

Here is the list of recent funding rounds of Bristol-Myers Squibb:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 01, 2019	7035444	Grant (prize money)	2254369	6748235	7720790	7031667
Feb 21, 2017	7383713	Post IPO	5306243	7235306	2327622	7450506
Oct 01, 2012	6722652	Grant (prize money)	9915770	2831981	6031935	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Bristol-Myers Squibb's funding rounds and investors

Bristol-Myers Squibb's employee count trend

Bristol-Myers Squibb has 38,151 employees as of Apr 26. Here is Bristol-Myers Squibb's employee count trend over the years:

Employee count trend for Bristol-Myers Squibb

Uncover Bristol-Myers Squibb's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bristol-Myers Squibb include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Bristol-Myers Squibb, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	Jindal ventures, Seaside Private Capital ... & 17 others	80/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
6th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	73/100
7th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	New Enterprise Associates, Digital Pharma Lab ... & 9 others	71/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	70/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	69/100
23rd	Bristol-Myers Squibb 1887, New York City (United States), Public	Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis	-	Berkshire Hathaway, Alcor Fund & 7 others	64/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Bristol-Myers Squibb's competitors? Click here to see the top ones

Bristol-Myers Squibb has made 87 investments in companies including RatioTX and Beeline Medicines. Bristol-Myers Squibb has also acquired 23 companies including Orbital Therapeutics and 2seventy bio.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 31, 2026	Investments	RatioTX	2021	Boston (United States)
Jun 30, 2026	Investments	Beeline Medicines	2025	Stamford (United States)
Oct 10, 2025	Acquisition	Orbital Therapeutics	2022	Yellow Springs (United States)

Want to know more about where corporates are investing? Sign up today!

See all investments and acquisitions by Bristol-Myers Squibb

Here is the latest report on Bristol-Myers Squibb's sector:

Free

Diversified Pharmaceuticals - Sector Report

Edition: July, 2026 (60 Pages)

View all reports related to Bristol-Myers Squibb

Media has covered Bristol-Myers Squibb for a total of 270 events in the last 1 year, 156 of them have been about company updates and 30 about partnerships.